FASEB J. Integrated DNA Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-128819.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-128819v1
23/9/2928    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Zhu, Y.
Right arrow Articles by Power, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, Y.
Right arrow Articles by Power, C.
(The FASEB Journal. 2009;23:2928-2941.)
© 2009 FASEB

CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy

Yu Zhu*,1, David Vergote*,1, Carlos Pardo{dagger}, Farshid Noorbakhsh*, Justin C. McArthur{dagger}, Morley D. Hollenberg{ddagger}, Christopher M. Overall§ and Christopher Power*,2

* Department of Medicine, University of Alberta, Edmonton, Alberta, Canada;

{dagger} Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA;

{ddagger} Department of Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada; and

§ Departments of Oral Biological and Medical Sciences and Biochemistry and Molecular Biology, Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada

2 Correspondence: Department of Medicine (Neurology), 6-11 Heritage Medical Research Centre, University of Alberta, Edmonton, AB T6G 2S2, Canada. E-mail: chris.power{at}ualberta.ca

Previous studies have implicated CXCL12 in the neuropathogenesis of HIV infection. Proteolysis of CXCL12 generates a neurotoxic molecule, CXCL12(5-67), which engages and activates CXCR3, in addition to exhibiting increased expression in the brains of patients with HIV-associated dementia (HAD). Herein, we investigated CXCR3-mediated neuronal injury, particularly, its contribution to autophagy suppression and the concomitant effects of antiretroviral therapy using human brain samples and models of HIV neuropathogenesis. Neurons in the brains of HAD patients and feline immunodeficiency virus (FIV)-infected animals, as well as cultured human neurons, expressed CXCR3, which was modulated in a ligand-specific manner. Exposure of human neurons to CXCL12(5-67) caused a reduction in the autophagy-associated molecule LC3 (P<0.05) and neuronal survival (P<0.05), which recapitulated findings in FIV- and HIV-infected brains (P<0.05). Oral didanosine (ddI) treatment of FIV-infected animals reduced neurobehavioral abnormalities in conjunction with diminished plasma viral load (P<0.05). F4/80 transcript abundance and CXCL12(5-67) immunoreactivity were reduced with restored neuronal LC3 expression in the brains of FIV-infected animals after ddI treatment (P<0.05). ddI treatment also prevented microglial activation and depletion of synaptic proteins in the cortex of FIV-infected animals (P<0.05). These findings indicate that the beneficial effects of ddI might be a consequence of a reduced systemic viral burden and concurrent leukocyte activation, leading to diminished neuroinflammation with preservation of neuronal autophagy by regulating CXCR3 activation.—Zhu, Y., Vergote, D., Pardo, C., Noorbakhsh, F., McArthur, J. C., Hollenberg, M. D., Overall, C. M., Power, C. CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy.


Key Words: HIV • FIV • neuroinflammation • CXCL12




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
T. P. Nguyen, V. M. Soukup, and B. B. Gelman
Persistent Hijacking of Brain Proteasomes in HIV-Associated Dementia
Am. J. Pathol., February 1, 2010; 176(2): 893 - 902.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Maingat, S. Viappiani, Y. Zhu, P. Vivithanaporn, K. K. Ellestad, J. Holden, C. Silva, and C. Power
Regulation of Lentivirus Neurovirulence by Lipopolysaccharide Conditioning: Suppression of CXCL10 in the Brain by IL-10
J. Immunol., February 1, 2010; 184(3): 1566 - 1574.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.